Karah Parschauer

Executive Officer at Amlogenyx.

Earliest Form D on file: Jul 2026

Filed Jul 9, 2026

Amlogenyx

Gene therapy that clears amyloid in Alzheimer's disease

Biotech, Novato CA

Named, Executive Officer.

$10M

sold of $20M offered

Network

At Amlogenyx

5 people

John Pinion
Executive Officer, signed as Chief Operating Officer
EMIL KAKKIS
Executive Officer, Director
CRAIG GORDON
Director
SUKUMAR NAGENDRAN
Director
TED HUIZENGA
Executive Officer